Financial Year |
March 31 2023 |
Monetary Funds |
1,976,534,538.54 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
6,808,060.00 |
Accounts Receivable |
2,395,299,103.53 |
Advances to Suppliers |
284,189,809.38 |
Other Receivables |
141,845,845.53 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
26,076,451.57 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
89,943,744.73 |
Total Current Assets |
4,920,697,553.28 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
14,051,812.52 |
Investment Properties |
-- |
Fixed Assetes |
209,950,177.70 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
30,780,410.36 |
R&D expenses |
2,936,589.23 |
Goodwill |
18,198,960.45 |
Long-Term Deferred and Prepaid Expenses |
25,158,826.61 |
Deferred Income Tax Assets |
107,348,016.86 |
Other Non-Current Assets |
151,470,000.00 |
Sub-Total of Non-Current Assets |
774,737,882.42 |
Total Assets |
5,695,435,435.70 |
Short-Term Loans |
824,813,194.03 |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
689,534,987.45 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
28,928,366.83 |
Taxes Payable |
26,540,244.82 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
168,619,207.28 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
36,470,479.85 |
Other Current Liabilities |
7,376,674.91 |
Sub-Total of Current Liabilities |
1,897,397,068.72 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
592,602.22 |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
40,380,020.71 |
Total Liabilities |
1,937,777,089.43 |
Paid-In Capital(Or Share Stock) |
1,807,747,642.00 |
Capital Surplus |
759,300,855.52 |
Surplus Reserve |
63,456,993.94 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
1,154,610,277.69 |
Minority Stockholder's Interest |
-27,115,689.10 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,784,774,035.37 |
Owner's Equity(Stockholder's Equity) |
3,757,658,346.27 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
5,695,435,435.70 |